Semaglutide for Weight Loss: Everything You Need to Know

Managing weight is rarely as simple as eating less and moving more. For many people, obesity is a complex, chronic condition that does not respond adequately to lifestyle changes alone. That is where medical science has been working to fill the gap.

Semaglutide has emerged as one of the most significant advances in weight management medicine in recent years. Clinical trials have shown results that were previously associated only with surgical intervention. But like any medical treatment, it comes with important considerations, and it works best as part of a structured, medically supervised programme.

Here is everything you need to know.

What Is Semaglutide?

Semaglutide belongs to a class of medications called glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 agonists. These drugs mimic a naturally occurring hormone in your gut called GLP-1, which is released after you eat.

Semaglutide was originally developed and used for over 15 years to treat type 2 diabetes, helping the body produce more insulin and regulate blood sugar levels. Researchers observed that patients taking it also experienced significant weight loss, which led to further investigation into its use specifically for weight management.

It is now approved for chronic weight management in adults who are living with obesity or who are overweight with at least one related health condition such as high blood pressure, high cholesterol, or type 2 diabetes.

How Does Semaglutide Work for Weight Loss?

Semaglutide works through two primary mechanisms that work together to reduce how much you eat.

First, it acts on the parts of the brain responsible for appetite and satiety. By mimicking the GLP-1 hormone at higher concentrations, semaglutide signals to your brain that you are full, reducing hunger and dampening cravings. Many people find that food simply becomes less appealing and that they feel satisfied with smaller portions.

Second, it slows gastric emptying, meaning food moves more slowly from your stomach into your small intestine. This extends the feeling of fullness after meals, making it easier to maintain a calorie deficit without the constant discomfort of hunger.

Together, these effects reduce overall calorie intake, which drives the weight loss seen in clinical trials. It is important to note that semaglutide works alongside a reduced-calorie diet and increased physical activity, not instead of them.

How Effective Is Semaglutide for Weight Loss?

The clinical evidence behind semaglutide is among the strongest ever seen for a weight loss medication.

In the landmark STEP 1 trial, nearly 2,000 adults with obesity or overweight were given either semaglutide or a placebo alongside lifestyle counselling over 68 weeks. The results were striking. Participants using semaglutide lost an average of 14.9% of their body weight, compared to just 2.4% in the placebo group. Around 86% of those on semaglutide lost at least 5% of their body weight, and half lost 15% or more.

To put this in perspective, a weight loss of 10% to 15% of body weight is associated with meaningful improvements in blood pressure, blood sugar, cholesterol, and overall cardiovascular risk. These are outcomes that lifestyle changes alone rarely achieve and that have historically required surgical intervention.

It is worth noting that results were achieved alongside structured lifestyle support, including dietary guidance and physical activity. Semaglutide is a powerful tool, but it delivers its best results when combined with healthy habits.

Benefits of Semaglutide Beyond Weight Loss

The benefits of semaglutide extend well beyond the number on the scale. In clinical trials, participants experienced improvements across several important health markers:

• Reduced blood pressure: Semaglutide was associated with meaningful reductions in systolic blood pressure, lowering cardiovascular risk.
• Better blood sugar control: Even in participants without diabetes, semaglutide improved fasting glucose and glycated haemoglobin levels. Among those with prediabetes at the start of the trial, 84% reverted to normal blood sugar levels by week 68.
• Improved cholesterol and lipid levels: Triglycerides and other cardiovascular risk markers improved significantly.
• Reduced waist circumference: Participants lost an average of over 13 cm from their waist, indicating a reduction in visceral fat, which is closely linked to metabolic disease.
• Better physical functioning: Participants reported significant improvements in their ability to perform everyday physical activities, along with better overall quality of life.
• Reduced inflammation: Levels of C-reactive protein, a key marker of inflammation associated with obesity-related disease, decreased with semaglutide use.

Semaglutide Tablets vs. Injectable Form

Semaglutide is available in two forms: a once-weekly injection administered under the skin, and an oral tablet taken daily.

The injectable form is the most widely studied and the version used in major clinical trials for weight management. It is administered using a pre-filled pen injector and is typically the form prescribed when semaglutide is used specifically for weight loss.

Semaglutide tablets for weight loss are also available and offer a needle-free alternative for those who prefer not to self-inject. However, oral semaglutide has lower bioavailability, meaning the body absorbs a smaller proportion of the drug. As a result, the dosing is different and must be carefully managed under medical supervision.

Both forms require a doctor's prescription and should only be started, adjusted, or stopped under medical guidance. Your doctor will assess your individual health profile and recommend the most appropriate form and dosage for you.

How Is Semaglutide Taken?

Semaglutide is started at a low dose and increased gradually to allow your body to adjust and to reduce the risk of side effects. A typical dosage schedule for the injectable form looks like this:

• Weeks 1 to 4: 0.25 mg once weekly. This is an introductory dose to help your body adapt.
• Weeks 5 to 8: 0.5 mg once weekly.
• Weeks 9 to 12: 1.0 mg once weekly.
• Weeks 13 to 16: 1.7 mg once weekly.
• Week 17 onwards: 2.4 mg once weekly. This is the maintenance dose for weight management.

If side effects become difficult to manage at any stage, your doctor may choose to keep you at a lower dose for longer before increasing. Never adjust your dose without medical advice.

Semaglutide injections are administered into the abdomen, thigh, or upper arm. Your doctor or nurse will show you how to do this correctly the first time.

Semaglutide Weight Loss Side Effects

Semaglutide is generally well tolerated, but side effects are common, particularly in the early weeks of treatment when your body is adjusting to the medication.

The most frequently reported side effects are gastrointestinal in nature. These include:

• Nausea
• Diarrhoea
• Vomiting
• Constipation
• Stomach pain or bloating

These effects are typically mild to moderate, tend to appear during the dose escalation phase, and improve over time as your body adapts. Starting on a lower dose and increasing gradually, as outlined above, helps significantly in managing these symptoms.

Less commonly, semaglutide has been associated with gallbladder-related issues, including gallstones. This is partly linked to the effects of rapid weight loss itself, which can promote gallstone formation.

In rare cases, pancreatitis has been reported. If you experience severe and persistent abdominal pain while taking semaglutide, contact your doctor promptly.

Some people also report dizziness, fatigue, and headaches, particularly in the early weeks. These usually resolve on their own.

Who Should Avoid Semaglutide?

Semaglutide is not suitable for everyone. You should not take it if you have:

• A personal or family history of medullary thyroid carcinoma
• Multiple endocrine neoplasia syndrome type 2 (MEN2)
• A history of pancreatitis
• Active gallbladder disease

It is also used with caution in people with a history of diabetic retinopathy, kidney disease, or those who are pregnant or breastfeeding.

If you are already taking medication for type 2 diabetes, it is essential to speak with your doctor before starting semaglutide, as combining certain diabetes medications requires careful management to avoid low blood sugar episodes.

Always consult your doctor before starting semaglutide. A thorough assessment of your medical history, current medications, and health goals will help determine whether it is the right option for you.

Is Semaglutide Safe for Long-Term Use?

Based on the evidence available, semaglutide has a reassuring safety profile for the duration studied in clinical trials, which extend to 68 weeks and beyond. It has also been used in type 2 diabetes management for over 15 years at lower doses, which provides additional safety context.

That said, long-term data specific to weight management doses is still being gathered, and ongoing monitoring by a healthcare provider remains essential throughout treatment.

One important consideration is what happens when you stop taking semaglutide. Studies have shown that a significant portion of the weight lost tends to return after discontinuation, particularly without continued dietary and lifestyle support. This underlines that semaglutide is a long-term management tool for a chronic condition, not a short course fix. Any decision to stop or continue treatment should be made in consultation with your doctor.

Monitoring Your Health While on Semaglutide

If you are on semaglutide or considering a GLP-1 diet as part of a medically supervised weight management programme, keeping track of your key health markers is an important part of the process.

As your weight changes, so do your blood sugar levels, cholesterol, blood pressure, and other metabolic indicators. Regular testing helps your doctor assess how well the treatment is working, detect any early concerns, and adjust your plan accordingly. This is particularly relevant if you are on GLP-1 agonists alongside other medications.

Metropolis Healthcare offers dedicated packages designed to support people on structured weight management programmes, including the GLP 1 Test Package and GLP-1 Monitor Package, which help you and your doctor track the markers that matter most during your treatment journey.

Frequently Asked Questions

How Long Does It Take for Semaglutide to Work?

Most people begin to notice a reduction in appetite within the first few weeks of starting semaglutide. However, meaningful weight loss typically becomes more visible from around 8 to 12 weeks onwards as the dose increases. The most significant results are seen around weeks 60 to 68, which is when weight loss in clinical trials reached its lowest point. It is important to stay consistent with your dose schedule, diet, and activity levels throughout.

What Are the Risks of Semaglutide for Weight Loss?

The most common risks are gastrointestinal side effects, including nausea, vomiting, diarrhoea, and constipation, which are usually mild and temporary. Less common but more serious risks include gallstones, pancreatitis, and, in those with a predisposing history, potential thyroid concerns. Your doctor will evaluate your personal risk profile before prescribing semaglutide and will monitor you throughout treatment to catch any issues early.

Can I Stop Taking Semaglutide Once I Reach My Goal Weight?

This is a conversation to have with your doctor rather than a decision to make on your own. Evidence suggests that weight tends to return after stopping semaglutide, especially without sustained lifestyle changes. Your doctor may recommend continuing at a maintenance dose, transitioning to a different approach, or gradually tapering the medication while reinforcing dietary and exercise habits. Stopping abruptly without a plan in place can undo the progress you have made.

Can Semaglutide Help with Type 2 Diabetes?

Yes. Semaglutide was originally developed as a diabetes medication and has been used to manage type 2 diabetes for many years at lower doses. It helps the body produce more insulin in response to meals and reduces the amount of glucose released by the liver, leading to better blood sugar control. For people who have both obesity and type 2 diabetes, semaglutide may offer the benefit of addressing both conditions simultaneously. Your endocrinologist or diabetologist will guide the appropriate dosing and monitoring plan.

Does Semaglutide Cause Dumping Syndrome?

Dumping syndrome, where food moves too quickly from the stomach into the small intestine, is not a recognised side effect of semaglutide. In fact, semaglutide works in the opposite direction by slowing gastric emptying, which means food stays in the stomach longer. Some of the gastrointestinal symptoms people experience with semaglutide, such as nausea and discomfort after eating, can feel similar to dumping syndrome but are caused by different mechanisms. If you are experiencing significant digestive discomfort, discuss it with your doctor.

Conclusion

Semaglutide represents a meaningful step forward in how medicine approaches obesity and chronic weight management. For the right person, used under careful medical supervision and alongside a healthy diet and active lifestyle, it can deliver results that go far beyond what most people achieve through lifestyle changes alone.

It is not a shortcut, and it is not suitable for everyone. But for those who qualify, it offers a clinically validated, evidence-backed option that addresses obesity as the complex medical condition it is.

If you are on a semaglutide programme or exploring medically supervised weight management, staying informed about your health through regular testing is just as important as the medication itself. Metropolis Healthcare offers a wide range of diagnostic tests and speciality health packages, including options designed to monitor your metabolic health throughout your weight management journey. With home sample collection available across a vast network, accurate results, and easy booking through the website, app, WhatsApp, or a quick call, Metropolis makes it simple to stay on top of the numbers that matter.

References

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185.
2. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740-756. PMID: 29617640.
3. Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017;6(2):187-194. PMID: 28455679.
4. Rubino DM, Greenway FL, Khalid U, et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial. JAMA. 2022;327(2):138-150. PMID: 35015037.
5. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971-984. PMID: 33667417.
6. Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Mol Metab. 2021;46:101102. PMID: 33068776.